Open access · US-GOV via ClinicalTrials.gov Clinical trial

Randomized-Controlled Trial of Metformin to Prevent Frailty in Pre-frail Elderly

Authors not listed

Universitas Indonesia · 2015

Dysbiosis Metformin Human Randomized controlled trial

Abstract

The purpose of this study is to investigate the effects of metformin to prevent frailty in pre-frail non-diabetic elderly. Several outcomes measured in this study are frailty status, quality of life, handgrip strength, gait speed, and serum myostatin levels. We hypothesize that metformin for 16 weeks could prevent frailty in pre-frail elderly.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-16 MST

Cite this

APA

Anonymous. (2015). Randomized-Controlled Trial of Metformin to Prevent Frailty in Pre-frail Elderly. <em>Universitas Indonesia</em>. https://clinicaltrials.gov/study/NCT02325245

Vancouver

Anonymous. Randomized-Controlled Trial of Metformin to Prevent Frailty in Pre-frail Elderly. Universitas Indonesia. 2015.

BibTeX

@misc{anon2015Random, title = {Randomized-Controlled Trial of Metformin to Prevent Frailty in Pre-frail Elderly}, author = {Anonymous}, journal = {Universitas Indonesia}, year = {2015}, }